(Q28569862)

https://api.crossref.org/works/10.1152%2FAJPENDO.00108.2011

Efficient adenoviral transduction of 3T3-F442A preadipocytes without affecting adipocyte differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00108.2011

Decreased UDP-GlcNAc levels abrogate proliferation control in EMeg32-deficient cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00108.2011

Abnormalities in signaling pathways in diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00108.2011

P38 mitogen-activated protein kinase mediates hexosamine-induced TGFbeta1 mRNA expression in human mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00108.2011

Nutrient sensor O-GlcNAc transferase regulates breast cancer tumorigenesis through targeting of the oncogenic transcription factor FoxM1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00108.2011

2',7'-Dichlorodihydrofluorescein as a fluorescent probe for reactive oxygen species measurement: Forty years of application and controversy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00108.2011

An analysis of high glucose and glucosamine-induced gene expression and oxidative stress in renal mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00108.2011

AMP-activated protein kinase and p38 MAPK activate O-GlcNAcylation of neuronal proteins during glucose deprivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00108.2011

p38(MAPK): stress responses from molecular mechanisms to therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00108.2011

Mechanisms and functions of p38 MAPK signalling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00108.2011

Evidence of O-linked N-acetylglucosamine in diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00108.2011

Hepatic glucose sensing via the CREB coactivator CRTC2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00108.2011

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00108.2011

Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00108.2011

Insulin-dependent activation of endothelial nitric oxide synthase is impaired by O-linked glycosylation modification of signaling proteins in human coronary endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00108.2011

Histopathology of diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00108.2011

Impact of Type 2 diabetes and aging on cardiomyocyte function and O-linked N-acetylglucosamine levels in the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00108.2011

Glucosamine cardioprotection in perfused rat hearts associated with increased O-linked N-acetylglucosamine protein modification and altered p38 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00108.2011

Activation of PKC-delta and SHP-1 by hyperglycemia causes vascular cell apoptosis and diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00108.2011

Activation of protein kinase C isoforms and its impact on diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00108.2011

Oxidative stress and diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00108.2011

The hexosamine pathway regulates the plasminogen activator inhibitor-1 gene promoter and Sp1 transcriptional activation through protein kinase C-beta I and -delta

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00108.2011

The Akt kinases: isoform specificity in metabolism and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00108.2011

Nox4 NAD(P)H oxidase mediates hypertrophy and fibronectin expression in the diabetic kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00108.2011

Akt down-regulation of p38 signaling provides a novel mechanism of vascular endothelial growth factor-mediated cytoprotection in endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00108.2011

The roles of ASK family proteins in stress responses and diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00108.2011

A PAI-1 mutant, PAI-1R, slows progression of diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00108.2011

FR167653 inhibits fibronectin expression and apoptosis in diabetic glomeruli and in high-glucose-stimulated mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00108.2011

Diabetic nephropathy: mechanisms of renal disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00108.2011

Loss of p53 enhances catalytic activity of IKKbeta through O-linked beta-N-acetyl glucosamine modification

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00108.2011

Akt phosphorylates and negatively regulates apoptosis signal-regulating kinase 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00108.2011

Protein O-GlcNAc modulates motility-associated signaling intermediates in neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00108.2011

High glucose-induced transforming growth factor beta1 production is mediated by the hexosamine pathway in porcine glomerular mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00108.2011

Protein O-GlcNAcylation: a new signaling paradigm for the cardiovascular system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00108.2011

Inhibition of O-GlcNAcase in perfused rat hearts by NAG-thiazolines at the time of reperfusion is cardioprotective in an O-GlcNAc-dependent manner.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00108.2011

Effect of a high dose of glucosamine on systemic and tissue inflammation in an experimental model of atherosclerosis aggravated by chronic arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00108.2011

Reactive oxygen species mediate high glucose-induced plasminogen activator inhibitor-1 up-regulation in mesangial cells and in diabetic kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00108.2011

Role of MKK3-p38 MAPK signalling in the development of type 2 diabetes and renal injury in obese db/db mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00108.2011

O-GlcNAcylation contributes to the vascular effects of ET-1 via activation of the RhoA/Rho-kinase pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00108.2011

Elevation of Global O-GlcNAc Levels in 3T3-L1 Adipocytes by Selective Inhibition of O-GlcNAcase Does Not Induce Insulin Resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00108.2011

Elevation of Global O-GlcNAc in rodents using a selective O-GlcNAcase inhibitor does not cause insulin resistance or perturb glucohomeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00108.2011

Selective decrease of membrane-associated PKC-alpha and PKC-epsilon in response to elevated intracellular O-GlcNAc levels in transformed human glial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00108.2011

Expression of glutamine:fructose-6-phosphate amidotransferase in human tissues: evidence for high variability and distinct regulation in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00108.2011

O-GlcNAc signaling in the cardiovascular system

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00108.2011

Augmented O-GlcNAc signaling attenuates oxidative stress and calcium overload in cardiomyocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00108.2011

Sustained expression of NADPH oxidase 4 by p38 MAPK-Akt signaling potentiates radiation-induced differentiation of lung fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00108.2011

Snail1 is stabilized by O-GlcNAc modification in hyperglycaemic condition

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00108.2011

RhoA/Rho-kinase contribute to the pathogenesis of diabetic renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00108.2011

A non-redundant role for MKP5 in limiting ROS production and preventing LPS-induced vascular injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00108.2011

The hexosamine biosynthesis inhibitor azaserine prevents endothelial inflammation and dysfunction under hyperglycemic condition through antioxidant effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00108.2011

Interplay between Akt and p38 MAPK pathways in the regulation of renal tubular cell apoptosis associated with diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00108.2011

p38 MAPK pathway is involved in high glucose-induced thioredoxin interacting protein induction in mouse mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00108.2011

The ERK cascade: a prototype of MAPK signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00108.2011

Hexosamine biosynthesis pathway flux promotes endoplasmic reticulum stress, lipid accumulation, and inflammatory gene expression in hepatic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00108.2011

Cyclic GMP kinase and RhoA Ser188 phosphorylation integrate pro- and antifibrotic signals in blood vessels

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00108.2011

Intracellular shuttling and mitochondrial function of thioredoxin-interacting protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00108.2011

Critical role of Nox4-based NADPH oxidase in glucose-induced oxidative stress in the kidney: implications in type 2 diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00108.2011

Aberrant O-GlcNAcylation characterizes chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00108.2011

Drosophila O-GlcNAc transferase (OGT) is encoded by the Polycomb group (PcG) gene, super sex combs (sxc).

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00108.2011

Hexosamine-induced fibronectin protein synthesis in mesangial cells is associated with increases in cAMP responsive element binding (CREB) phosphorylation and nuclear CREB: the involvement of protein kinases A and C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00108.2011

O-GlcNAc signaling: a metabolic link between diabetes and cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00108.2011

Regulation of Akt signaling by O-GlcNAc in euglycemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00108.2011

Differential activation of the JNK signal pathway by UV irradiation and glucose deprivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00108.2011

In vivo modulation of O-GlcNAc levels regulates hippocampal synaptic plasticity through interplay with phosphorylation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00108.2011

Dominant-negative p38alpha mitogen-activated protein kinase prevents cardiac apoptosis and remodeling after streptozotocin-induced diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00108.2011

High glucose-enhanced activation of mesangial cell p38 MAPK by ET-1, ANG II, and platelet-derived growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00108.2011

A robust approach for the quantitation of viral concentration in an adenoviral vector-based human immunodeficiency virus vaccine by real-time quantitative polymerase chain reaction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00108.2011

Cross-talk between GlcNAcylation and phosphorylation: site-specific phosphorylation dynamics in response to globally elevated O-GlcNAc

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00108.2011

O-linked β-N-acetylglucosamine transferase is indispensable in the failing heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00108.2011

Chronic exposure of human mesangial cells to high glucose environments activates the p38 MAPK pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00108.2011

Mesangial cell NADPH oxidase upregulation in high glucose is protein kinase C dependent and required for collagen IV expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00108.2011

Increased protein O-GlcNAc modification inhibits inflammatory and neointimal responses to acute endoluminal arterial injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00108.2011

NFkappaB activation is associated with its O-GlcNAcylation state under hyperglycemic conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00108.2011

Apoptosis signal-regulating kinase 1 mediates cellular senescence induced by high glucose in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00108.2011

AKT2 inhibition of cisplatin-induced JNK/p38 and Bax activation by phosphorylation of ASK1: implication of AKT2 in chemoresistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00108.2011

A potent mechanism-inspired O-GlcNAcase inhibitor that blocks phosphorylation of tau in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00108.2011

Dynamic O-GlcNAc modification of nucleocytoplasmic proteins in response to stress. A survival response of mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00108.2011

Glucosamine improves cardiac function following trauma-hemorrhage by increased protein O-GlcNAcylation and attenuation of NF-{kappa}B signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00108.2011